Literature DB >> 15370222

Intracranial presentation of systemic Hodgkin's disease.

Khalid Hirmiz1, Annette Foyle, Derek Wilke, Steven Burrell, Robert Brownstone, Casely Ago, Rajbir Pahil, Stephen Couban.   

Abstract

Intracranial involvement by Hodgkin's disease is rare. We report a patient with Hodgkin's disease who had intracranial disease at presentation. We also review the literature pertaining to intracranial Hodgkin's disease. Using the key words "Hodgkin's disease" and "central nervous system (CNS) disease", we searched the Pubmed and Cancerlit databases. References were systematically reviewed and data regarding the following variables was extracted: age, gender, signs and symptoms at presentation, histology of Hodgkin's disease, cerebrospinal fluid analysis, stage and treatment. Only 36 cases of intracranial Hodgkin's disease were identified in the literature. Intracranial Hodgkin's disease at presentation is even more uncommon with only 8 reported cases. Most cases of intracranial involvement by Hodgkin's disease occur at the time of relapse. The most common presenting feature of intracranial Hodgkin's disease is a cranial nerve palsy with brain parenchyma being the most common intracranial site of involvement. Mixed cellularity histology is the most frequent subtype of Hodgkin's disease among these patients and the median survival following intracranial presentation is 46 months. Treatment has varied extensively but includes whole brain radiation with or without combination chemotherapy. Our literature review suggests that the prognosis is not dismal with appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370222     DOI: 10.1080/10428190410001673409

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  12 in total

1.  Dural lesions mimicking meningiomas: A pictorial essay.

Authors:  Danai Chourmouzi; Stamatia Potsi; Anestis Moumtzouoglou; Elisavet Papadopoulou; Kostas Drevelegas; Thomas Zaraboukas; Antonios Drevelegas
Journal:  World J Radiol       Date:  2012-03-28

2.  Central nervous system involvement in Hodgkin's lymphoma.

Authors:  L Galán; A C Sánchez; B Cantos; M Provencio
Journal:  Med Oncol       Date:  2010-10-14       Impact factor: 3.064

3.  Intracranial Hodgkin's disease.

Authors:  V Gupta; J Ghosh; P Pant; B D Bhatia
Journal:  Indian J Pediatr       Date:  2006-04       Impact factor: 1.967

4.  Central nervous system Hodgkin lymphoma: case report and review of the literature.

Authors:  Sara Torgerson; Horatiu Olteanu; Matthew Tinguely; Timothy S Fenske
Journal:  J Neurooncol       Date:  2010-07-31       Impact factor: 4.130

5.  CNS Hodgkin lymphoma.

Authors:  Elizabeth R Gerstner; Lauren E Abrey; David Schiff; Andrés J M Ferreri; Andrew Lister; Silvia Montoto; Richard Tsang; Eckhard Thiel; Francesc Graus; Dirk Behringer; Gerald Illerhaus; Susan Weaver; Patrick Wen; Alfredo Voloschin; Nancy Lee Harris; Tracy T Batchelor
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

Review 6.  Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment: case report and review of the literature.

Authors:  Christoph Henkenberens; Anke Franzke; Peter Raab; Ilske Oschlies; Wolfram Klapper; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2014-05-14       Impact factor: 3.621

7.  Hodgkin's Lymphoma: A Review of Neurologic Complications.

Authors:  Sean Grimm; Marc Chamberlain
Journal:  Adv Hematol       Date:  2010-10-11

Review 8.  Dural masses: meningiomas and their mimics.

Authors:  Daniel Lyndon; Joseph A Lansley; Jane Evanson; Anant S Krishnan
Journal:  Insights Imaging       Date:  2019-02-06

9.  A sarcoidosis-lymphoma syndrome revealed by hypopituitarism.

Authors:  Charlotte Delcourt; Halil Yildiz; Alessandra Camboni; Eric Van den Neste; Véronique Roelants; Alexandra Kozyreff; Jean Paul Thissen; Dominique Maiter; Raluca Maria Furnica
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-09-27

10.  Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications.

Authors:  Abhishek R Keraliya; Sree Harsha Tirumani; Atul B Shinagare; Nikhil H Ramaiya
Journal:  Insights Imaging       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.